We are live on ! Find out more

2,804 hedge funds and large institutions have $160B invested in Pfizer in 2021 Q3 according to their latest regulatory filings, with 192 funds opening new positions, 1,218 increasing their positions, 1,120 reducing their positions, and 87 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more first-time investments, than exits

New positions opened: 192 | Existing positions closed: 87

51% more funds holding in top 10

Funds holding in top 10: 70106 (+36)

10% more capital invested

Capital invested by funds: $145B → $160B (+$14.6B)

3% more funds holding

Funds holding: 2,7332,804 (+71)

10% more call options, than puts

Call options by funds: $3.51B | Put options by funds: $3.19B

9% more repeat investments, than reductions

Existing positions increased: 1,218 | Existing positions reduced: 1,120

0.07% less ownership

Funds ownership: 66.48%66.41% (-0.07%)

Holders
2,804
Holders Change
+71
Holders Change %
+2.6%
% of All Funds
49.08%
Holding in Top 10
106
Holding in Top 10 Change
+36
Holding in Top 10 Change %
+51.43%
% of All Funds
1.86%
New
192
Increased
1,218
Reduced
1,120
Closed
87
Calls
$3.51B
Puts
$3.19B
Net Calls
+$317M
Net Calls Change
+$557M
Name Holding Trade Value Shares
Change
Change in
Stake
BSA
1276
Bull Street Advisors
Georgia
$2.27M +$51.4K +1,160 +2%
DWA
1277
Douglass Winthrop Advisors
New York
$2.27M -$19.2K -433 -0.8%
PCA
1278
Peddock Capital Advisors
Massachusetts
$2.27M +$11.8K +267 +0.5%
CWM
1279
Concentric Wealth Management
California
$2.26M -$32.1K -725 -1%
FMTC
1280
Farmers & Merchants Trust Company
California
$2.25M +$110K +2,479 +5%
DF
1281
Donoghue Forlines
Massachusetts
$2.25M +$971K +21,925 +72%
AR
1282
Advisory Research
Illinois
$2.25M +$2.32M +52,439 New
GP
1283
Girard Partners
Pennsylvania
$2.25M -$83.6K -1,886 -3%
CWM
1284
Cornerstone Wealth Management
Missouri
$2.25M +$85.4K +1,928 +4%
LS
1285
Leelyn Smith
Illinois
$2.25M +$21.5K +485 +0.9%
GH
1286
GAM Holding
Switzerland
$2.24M +$1.37K +31 +0.1%
HI
1287
Hudock Inc
Pennsylvania
$2.24M +$6.03K +136 +0.3%
PGIM
1288
Pacific Global Investment Management
California
$2.24M -$107K -2,424 -4%
NSEDCP
1289
NJ State Employees Deferred Compensation Plan
New Jersey
$2.23M
WTB
1290
Washington Trust Bank
Washington
$2.23M +$323K +7,285 +16%
ST
1291
Somerset Trust
Pennsylvania
$2.23M +$156K +3,517 +7%
CNBTD
1292
Citizens National Bank Trust Department
Mississippi
$2.23M -$332K -7,500 -13%
SWM
1293
Sculati Wealth Management
Michigan
$2.23M +$113K +2,540 +5%
PFS
1294
Physicians Financial Services
North Carolina
$2.23M +$462K +10,420 +25%
WBC
1295
West Branch Capital
Massachusetts
$2.22M +$2.66K +60 +0.1%
SM
1296
Sciencast Management
New Jersey
$2.22M +$2.39M +53,891 New
KTC
1297
Kistler-Tiffany Companies
Pennsylvania
$2.22M +$47K +1,061 +2%
IA
1298
IFG Advisory
Georgia
$2.22M +$224K +5,055 +11%
HFM
1299
Hartford Financial Management
Connecticut
$2.21M +$6.47K +146 +0.3%
SIM
1300
Sentry Investment Management
Wisconsin
$2.2M -$371K -8,369 -14%

PFE Hedge Fund Activity: Q3 2021 in Review

2,804 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q3 2021, worth a combined $160B — up 10% from $145B a quarter earlier.

Buyers outnumbered sellers: 192 funds opened new PFE positions and 87 closed out — a net gain of 105 holders — while 1,218 added to existing stakes and 1,120 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $660M. The largest seller was Wellington Management Group, cutting an estimated $920M.

  • 2,804 institutional investors held Pfizer (PFE) as of Q3 2021, up from 2,733 in Q2 2021.
  • Funds reported $160B of Pfizer stock for Q3 2021, up 10% quarter-over-quarter.
  • 192 funds opened new Pfizer positions in Q3 2021 and 87 closed out, a net change of +105 holders.
  • The largest Pfizer buyer in Q3 2021 was T. Rowe Price Associates, an estimated $660M added.
  • The largest Pfizer seller in Q3 2021 was Wellington Management Group, an estimated $920M sold.

Based on aggregated 13F filings for Q3 2021.